GlassScriptPhysician profile
Angie Goodman
NPI 1790002004
$4,824.90
in general payments reported to CMS, 2019-2025
30 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $78.30 · 2021: $404 · 2022: $493 · 2023: $1,975 · 2024: $291 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318 · Travel and Lodging: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.75 |
| Travel and Lodging | $1,217.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,780.83 | 2019-2025 | Portfolio, R3flex, Ankle Fracture |
| Cdc Medical LLC | $872.00 | 2019 | |
| Novo Nordisk INC | $554.43 | 2019-2023 | Wegovy, Ozempic, Rybelsus |
| Stryker Corporation | $341.32 | 2019-2025 | Variax, Prophecy, Gravity |
| Medtronic, INC. | $161.99 | 2024 | Hawkone |
| Wright Medical Technology, INC. | $130.81 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.70 | 2021-2023 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $83.96 | 2021-2023 | |
| Bioventus LLC | $68.36 | 2021-2023 | Nexus |
| Mimedx Group, INC. | $65.90 | 2024-2025 | |
| Smith+Nephew, INC. | $61.56 | 2023-2025 | Grafix Pl, Stravix Pl |
| Abbvie INC. | $60.49 | 2022-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.33 | 2020-2023 | Jublia |
| Integra Lifesciences Corporation | $55.82 | 2020-2022 | |
| Kerecis Limited | $50.09 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $44.93 | 2021 | |
| Orthofix Medical, INC. | $44.61 | 2019-2022 | |
| Pfizer INC. | $41.73 | 2019 | |
| Merck Sharp & Dohme LLC | $38.59 | 2019-2021 | |
| Organogenesis INC. | $32.79 | 2021-2023 | Puraply |
| Otsuka America Pharmaceutical, INC. | $29.55 | 2021 | |
| Arthrosurface Incorporated | $25.36 | 2019-2020 | |
| Abbott Laboratories | $21.91 | 2022 | |
| Nevro Corp. | $21.90 | 2024 | Senza |
| Nexus Medical Technologies LLC | $21.33 | 2025 | |
| Treace Medical Concepts, INC. | $16.34 | 2022 | |
| Grt US Holding, INC. | $14.91 | 2021 | |
| Averitas Pharma INC. | $14.68 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $11.91 | 2021 | |
| Rock Medical Orthopedics, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.